Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.
Jawale CV, Chaudhari AA, Jeon BW, Nandre RM, Lee JH.
Infect Immun. 2012 Apr;80(4):1502-9. Epub 2012 Jan 30.
Related citations
A hybrid multistage protein vaccine induces protective immunity against murine malaria.
Singh B, Cabrera-Mora M, Jiang J, Moreno A.
Infect Immun. 2012 Apr;80(4):1491-501. Epub 2012 Jan 17.
Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.
Hegazy WA, Xu X, Metelitsa L, Hensel M.
Infect Immun. 2012 Mar;80(3):1193-202. Epub 2012 Jan 17.
Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.
Szczepanek SM, Majumder S, Sheppard ES, Liao X, Rood D, Tulman ER, Wyand S, Krause DC, Silbart LK, Geary SJ.
Infect Immun. 2012 Mar;80(3):1007-14. Epub 2012 Jan 17.
O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages.
Clemens DL, Lee BY, Horwitz MA.
Infect Immun. 2012 Mar;80(3):952-67. Epub 2011 Dec 27.
Broadly protective Shigella vaccine based on type III secretion apparatus proteins.
Martinez-Becerra FJ, Kissmann JM, Diaz-McNair J, Choudhari SP, Quick AM, Mellado-Sanchez G, Clements JD, Pasetti MF, Picking WL.
Infect Immun. 2012 Mar;80(3):1222-31. Epub 2011 Dec 27.
Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.
Infect Immun. 2012 Mar;80(3):1166-80. Epub 2011 Dec 12.
Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.
Juárez-Rodríguez MD, Arteaga-Cortés LT, Kader R, Curtiss R 3rd, Clark-Curtiss JE.
Infect Immun. 2012 Feb;80(2):798-814. Epub 2011 Dec 5.
Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.
Juárez-Rodríguez MD, Yang J, Kader R, Alamuri P, Curtiss R 3rd, Clark-Curtiss JE.
Infect Immun. 2012 Feb;80(2):815-31. Epub 2011 Dec 5.
Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant.
Kong Q, Six DA, Liu Q, Gu L, Roland KL, Raetz CR, Curtiss R 3rd.
Infect Immun. 2011 Dec;79(12):5027-38. Epub 2011 Sep 19. Erratum in: Infect Immun. 2012 Mar;80(3):1302.
Mouse monoclonal antibodies to anthrax edema factor protect against infection.
Leysath CE, Chen KH, Moayeri M, Crown D, Fattah R, Chen Z, Das SR, Purcell RH, Leppla SH.
Infect Immun. 2011 Nov;79(11):4609-16. Epub 2011 Sep 12.
Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
Olafsdottir TA, Lingnau K, Nagy E, Jonsdottir I.
Infect Immun. 2012 Jan;80(1):461-8. Epub 2011 Oct 24.
Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
Wu T, Grassel C, Levine MM, Barry EM.
Infect Immun. 2011 Dec;79(12):4912-22. Epub 2011 Oct 3.
The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
Norris MH, Propst KL, Kang Y, Dow SW, Schweizer HP, Hoang TT.
Infect Immun. 2011 Oct;79(10):4010-8. Epub 2011 Aug 1.
Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.
Kong Q, Yang J, Liu Q, Alamuri P, Roland KL, Curtiss R 3rd.
Infect Immun. 2011 Oct;79(10):4227-39. Epub 2011 Jul 18.
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.
Chimalapati S, Cohen J, Camberlein E, Durmort C, Baxendale H, de Vogel C, van Belkum A, Brown JS.
Infect Immun. 2011 Dec;79(12):4965-76. Epub 2011 Sep 26.
In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain.
Spears PA, Suyemoto MM, Hamrick TS, Wolf RL, Havell EA, Orndorff PE.
Infect Immun. 2011 Dec;79(12):5001-9. Epub 2011 Sep 19.
Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.
Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, Zhou H, Long CA, Sattabongkot J, Thompson J, Wilson DW, Beeson JG, Healer J, Crabb BS, Cowman AF, Torii M, Tsuboi T.
Infect Immun. 2011 Nov;79(11):4523-32. Epub 2011 Sep 6.
Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.
Cron LE, Stol K, Burghout P, van Selm S, Simonetti ER, Bootsma HJ, Hermans PW.
Infect Immun. 2011 Sep;79(9):3697-710. Epub 2011 Jul 18.
Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.
Arenas-Gamboa AM, Rice-Ficht AC, Kahl-McDonagh MM, Ficht TA.
Infect Immun. 2011 Sep;79(9):3653-8. Epub 2011 Jun 27. Erratum in: Infect Immun. 2011 Dec;79(12):5040.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on